Could stem cells ease MS symptoms? new trial tests hope
NCT ID NCT06800404
First seen Nov 20, 2025 · Last updated Apr 24, 2026 · Updated 24 times
Summary
This study tests a new stem cell treatment (HB-adMSCs) for people with relapsing-remitting multiple sclerosis (RRMS). The goal is to see if multiple infusions of the patient's own stem cells can improve quality of life and reduce disability. Ten adults who previously received a placebo in an earlier trial are taking part. The study is active but no longer recruiting new participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hope Biosciences Research Foundation
Sugar Land, Texas, 77479, United States
Conditions
Explore the condition pages connected to this study.